First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy
暂无分享,去创建一个
K. Nikolaou | U. Kramer | M. Notohamiprodjo | F. Fend | A. Stenzl | J. Bedke | S. Rausch | M. Scharpf | J. Mischinger | S. Kaufmann | S. Kruck | B. Amend | S. Rausch | M. Adam | Sascha Kaufmann | Bastian Amend | Arnulf Stenzl | Falko Fend | Jens Bedke | Stephan Kruck | Meike Adam | Ulrich Kramer | Konstantin Nikolaou
[1] P. Pepe,et al. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer , 2017, Clinical genitourinary cancer.
[2] G. Nabi,et al. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies , 2016, World Journal of Urology.
[3] Saila Kauppila,et al. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. , 2016, European urology.
[4] Osamu Ukimura,et al. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. , 2016, European urology.
[5] K. Nikolaou,et al. Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer , 2016, World Journal of Urology.
[6] A. Cheng,et al. The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy‐related infection over 5 years , 2015, BJU international.
[7] Erhard Godehardt,et al. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. , 2015, European urology.
[8] Pierre Mozer,et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. , 2015, European urology.
[9] Baris Turkbey,et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.
[10] Heinz-Peter Schlemmer,et al. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. , 2015, The Journal of urology.
[11] M. Roethke,et al. Direct Comparison of Targeted MRI-Guided Biopsy with Systematic Transrectal Ultrasound-Guided Biopsy in Patients with Previous Negative Prostate Biopsies , 2014, Urologia Internationalis.
[12] Tobias Penzkofer,et al. Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities – a radiologist's perspective , 2014, NMR in biomedicine.
[13] K. Kihara,et al. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. , 2014, European urology.
[14] J. Fütterer,et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.
[15] F. Aragona,et al. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. , 2013, Urology.
[16] Shyam Natarajan,et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.
[17] P. Johnstone,et al. Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance. , 2012, Urology.
[18] J. Raman,et al. Complications following prostate needle biopsy requiring hospital admission or emergency department visits – experience from 1000 consecutive cases , 2012, BJU international.
[19] D. Schilling,et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy , 2012, World Journal of Urology.
[20] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[21] P Mohan,et al. Robotic transperineal prostate biopsy: pilot clinical study. , 2011, Urology.
[22] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[23] Y. Naya,et al. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings. , 2006, Urology.
[24] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[25] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[26] T Falco,et al. Ultrasound imaging for external-beam prostate treatment setup and dosimetric verification. , 2002, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[27] C. Abbou,et al. EAU guidelines on prostate cancer. , 2009, European urology.